Revenue $2.75B, up 8.7% on a year earlier. Acetyl Chain Net Sales $1.33B, up 19.2%. Engineered Materials Net Sales $1.45B, up 0.3%. Diluted EPS $1.13 against $1.80.
| Q2 FY26 | Q1 FY26 | Q2 FY25 | Year over year | |
|---|---|---|---|---|
| Revenue | $2.75B | $2.34B | $2.53B | +8.7% |
| Operating income | $276.00M | $214.00M | $233.00M | +18.5% |
| Net income | $125.00M | $44.00M | $202.00M | -38.1% |
| Diluted EPS | $1.13 | $0.40 | $1.80 | |
| Operating cash flow | $209.00M | $76.00M | $410.00M | -49.0% |
| Capital expenditures | -$62.00M | -$66.00M | -$93.00M | |
| Free cash flow | $147.00M | $10.00M | $317.00M | -53.6% |
| Q2 FY26 | Q2 FY25 | Year over year | |
|---|---|---|---|
| Acetyl Chain Net Sales | $1.33B | $1.11B | +19.2% |
| Engineered Materials Net Sales | $1.45B | $1.44B | +0.3% |
The week's biggest guidance misses, KPI surprises and one chart.
Stock Atlas, “Celanese (CE) Q2 FY26 earnings: results and KPIs”, stockatlas.com/companies/CE/earnings/2026-q2/, data as of 3 November 2026. Links to this page are welcome.
